Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barreiro

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Journal of Crohn'S & Colitis|April 13, 2019
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel DiseaseM Chaparro, A Garre, M F Guerra Veloz, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2018
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control studyM Mañosa, M Calafat, R de Francisco, et al.
Computing in Science & Engineering|September 4, 2012
Nanoinformatics: developing new computing applications for nanomedicineV Maojo, M Fritts, F Martin-Sanchez, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 25, 2024
Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCUF Mesonero, Y Zabana, A Fernández-Clotet, et al.
United European Gastroenterology Journal|April 30, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida RegistryM Iborra, B Botella, M D Martín-Arranz, et al.
The American Journal of Gastroenterology|December 14, 2016
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up StudyM J Casanova, M Chaparro, V García-Sánchez, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.
The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.
Journal of Crohn'S & Colitis|April 13, 2019
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel DiseaseM Chaparro, A Garre, M F Guerra Veloz, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2018
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control studyM Mañosa, M Calafat, R de Francisco, et al.
Computing in Science & Engineering|September 4, 2012
Nanoinformatics: developing new computing applications for nanomedicineV Maojo, M Fritts, F Martin-Sanchez, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 25, 2024
Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCUF Mesonero, Y Zabana, A Fernández-Clotet, et al.
United European Gastroenterology Journal|April 30, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida RegistryM Iborra, B Botella, M D Martín-Arranz, et al.
The American Journal of Gastroenterology|December 14, 2016
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up StudyM J Casanova, M Chaparro, V García-Sánchez, et al.
Pageof 8